Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Howard M Lederman

Showing results (41-50 of 50) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 50 results.
Journal of Pediatric Hematology/Oncology|November 20, 2019
Retrospective Diagnosis of Ataxia-Telangiectasia in an Adolescent Patient With a Remote History of T-Cell LeukemiaSei-Gyung K Sze, Howard M Lederman, Thomas O Crawford, et al.
Orphanet Journal of Rare Diseases|February 15, 2024
Transcriptional profiling of peripheral blood mononuclear cells identifies inflammatory phenotypes in Ataxia TelangiectasiaSylvia N Michki, Benjamin D Singer, Javier V Perez, et al.
Annals of Internal Medicine|July 29, 2020
Desperate Times: Protecting the Public From Research Without Consent or Oversight During Public Health EmergenciesMary Catherine Beach, Howard M Lederman, Megan Singleton, et al.
The Journal of Allergy and Clinical Immunology|November 9, 2024
Prevalence and outcomes of cancer and treatment-associated toxicities for patients with ataxia telangiectasiaAimee Magnarelli, Qi Liu, Fan Wang, et al.
The Journal of Infectious Diseases|December 16, 2003
Incomplete immune reconstitution after initiation of highly active antiretroviral therapy in human immunodeficiency virus-infected patients with severe CD4+ cell depletionHoward M Lederman, Paige L Williams, Julia W Wu, et al.
Pediatric Pulmonology|June 29, 2010
Evaluation and management of pulmonary disease in ataxia-telangiectasiaSharon A McGrath-Morrow, W Adam Gower, Cynthia Rothblum-Oviatt, et al.
The Journal of Allergy and Clinical Immunology|January 17, 2017
Patterns of immune development in urban preschoolers with recurrent wheeze and/or atopyJames E Gern, Agustin Calatroni, Katy F Jaffee, et al.
Frontiers in Neurology|February 7, 2025
Long-term safety of dexamethasone sodium phosphate encapsulated in autologous erythrocytes in pediatric patients with ataxia telangiectasiaMary Kay Koenig, Vincenzo Leuzzi, Riadh Gouider, et al.
The Journal of Allergy and Clinical Immunology|March 4, 2014
Recommendations for live viral and bacterial vaccines in immunodeficient patients and their close contacts, William T Shearer, Thomas A Fleisher, et al.
JCI Insight|December 2, 2021
Pharmacokinetics of high-titer anti-SARS-CoV-2 human convalescent plasma in high-risk childrenOren Gordon, Mary Katherine Brosnan, Steve Yoon, et al.
Pageof 5

Showing results (41-50 of 50) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
Journal of Pediatric Hematology/Oncology|November 20, 2019
Retrospective Diagnosis of Ataxia-Telangiectasia in an Adolescent Patient With a Remote History of T-Cell LeukemiaSei-Gyung K Sze, Howard M Lederman, Thomas O Crawford, et al.
Orphanet Journal of Rare Diseases|February 15, 2024
Transcriptional profiling of peripheral blood mononuclear cells identifies inflammatory phenotypes in Ataxia TelangiectasiaSylvia N Michki, Benjamin D Singer, Javier V Perez, et al.
Annals of Internal Medicine|July 29, 2020
Desperate Times: Protecting the Public From Research Without Consent or Oversight During Public Health EmergenciesMary Catherine Beach, Howard M Lederman, Megan Singleton, et al.
The Journal of Allergy and Clinical Immunology|November 9, 2024
Prevalence and outcomes of cancer and treatment-associated toxicities for patients with ataxia telangiectasiaAimee Magnarelli, Qi Liu, Fan Wang, et al.
The Journal of Infectious Diseases|December 16, 2003
Incomplete immune reconstitution after initiation of highly active antiretroviral therapy in human immunodeficiency virus-infected patients with severe CD4+ cell depletionHoward M Lederman, Paige L Williams, Julia W Wu, et al.
Pediatric Pulmonology|June 29, 2010
Evaluation and management of pulmonary disease in ataxia-telangiectasiaSharon A McGrath-Morrow, W Adam Gower, Cynthia Rothblum-Oviatt, et al.
The Journal of Allergy and Clinical Immunology|January 17, 2017
Patterns of immune development in urban preschoolers with recurrent wheeze and/or atopyJames E Gern, Agustin Calatroni, Katy F Jaffee, et al.
Frontiers in Neurology|February 7, 2025
Long-term safety of dexamethasone sodium phosphate encapsulated in autologous erythrocytes in pediatric patients with ataxia telangiectasiaMary Kay Koenig, Vincenzo Leuzzi, Riadh Gouider, et al.
The Journal of Allergy and Clinical Immunology|March 4, 2014
Recommendations for live viral and bacterial vaccines in immunodeficient patients and their close contacts, William T Shearer, Thomas A Fleisher, et al.
JCI Insight|December 2, 2021
Pharmacokinetics of high-titer anti-SARS-CoV-2 human convalescent plasma in high-risk childrenOren Gordon, Mary Katherine Brosnan, Steve Yoon, et al.
Pageof 5